Dr. J. Jacques Carter

Dr. J. Jacques Carter

Aug 3, 2025

Primary Care Physician

Primary Care Physician

Harvard Medical School

Dr. J. Jacques Carter currently serves as an attending physician at the Beth Israel Deaconess Medical Center in Boston and is an assistant professor of medicine at Harvard Medical School. From 2005 to 2014, he also served as the Medical Director of the Prostate Cancer Screening and Education Program at the Dana-Farber Cancer Institute in Boston. Dr. Carter serves as a medical advisor for PHEN and a member of its board of directors. 

Dr. Carter has been active in a number of civic and community organizations, including past board president of the Family Service of Greater Boston and past chair of the Brookline Advisory Council on Public Health. 

He has earned degrees from Howard University and George Washington University and received his medical degree from Georgetown University in Washington, D.C. Dr. Carter completed his residency training in Internal Medicine at Beth Israel Deaconess Medical Center in Boston. Then, Dr. Carter completed a graduate program at the Harvard School of Public Health where he received his Master of Public Health (MPH) degree. 

He then completed a clinical fellowship in primary care medicine at Massachusetts General Hospital. Since completing his training, Dr. Carter has held a number of clinical and administrative positions, including medical directorships of several local and national healthcare organizations. 

As a former director of one of the major clinical clerkships, he now serves as a teacher, advisor, and mentor for students at Harvard College, Harvard Medical School, and the School of Public Health. He regularly gives talks on medical and health-related topics to community groups and students throughout the Greater Boston area. He also lectures nationally and internationally on medical and public health topics. Dr. Carter serves as a medical consultant and resource for members of the print and electronic media.  

Go To Session:

Dr. John B. Wong

Dr. John B. Wong

Aug 31, 2023

Vice Chair of Academic Affairs in the Department of Medicine, Member of the USPSTF Task Force

Vice Chair of Academic Affairs in the Department of Medicine, Member of the USPSTF Task Force

Tufts Medical Center

John B Wong, MD is a primary care general internist and Vice Chair of Academic Affairs in the Department of Medicine at Tufts Medical Center and a Professor of Medicine at the Tufts University School of Medicine. He is a member of the US Preventive Services Task Force, a Master of the American College of Physicians, a past president of the Society for Medical Decision Making, and an Associate Statistical Editor at the Annals of Internal Medicine. His research focuses on the application of decision analysis to help patients, clinicians, and policymakers choose among alternative tests, treatments or policies, thereby promoting rational evidence-based efficient and effective patient-centered care that reflects individualized risk assessment and patient preferences. He received his BS with honors from Haverford College and MD from the University of Chicago and completed residency and medical informatics fellowship in Clinical Decision Making in Internal Medicine at Tufts Medical Center.

Go To Session:

Congressman Gregory Meeks

Congressman Gregory Meeks

Aug 16, 2023

U.S. House of Representatives

U.S. House of Representatives

New York D-5

From public housing to the nation’s Capital, Gregory Weldon Meeks has lived a true American success story. Known for his compassionate and tenacious representation of his constituents, and his coalition-building skills, Meeks proudly serves the constituents of New York’s Fifth Congressional District in the U.S. House of Representatives

Go To Session:

Dr. Curtis A. Pettaway

Dr. Curtis A. Pettaway

Aug 3, 2023

Professor, Department of Urology

Professor, Department of Urology

MD Anderson Cancer Center

Dr. Curtis Pettaway is a Professor of Urology at The University of Texas MD Anderson Cancer Center in Houston, Texas. His clinical practice is based on treating patients with genitourinary malignancies, including penile, urethral, and prostate malignancies. The goals of his prostate-related studies are to further define the host and molecular markers of cancer progression and to reduce disparities in prostate cancer outcomes among African Americans and the underserved by studying both the clinical and biological correlates of aggressive disease.

He has served as the Medical Director of the Prostate Outreach Project (POP), an initiative that has educated and screened more than 5,000 men. Dr. Pettaway has also served as the Co-Director of a National Cancer Institute-funded study evaluating the influence of West African ancestry on the incidence and aggressiveness of prostate cancer among African American and Puerto Rican populations.

Go To Session:

Dr. Daniel Barocas

Dr. Daniel Barocas

Aug 3, 2023

Professor, Department of Urology

Professor, Department of Urology

Vanderbilt University Medical Center

Dr. Daniel Barocas is an accomplished researcher who focuses on quality of life, quality of care, healthcare disparities, and comparative effectiveness. He is the principal investigator of a multi-center study on the effectiveness and side effects of different treatments for prostate cancer.

Go To Session:

Dr. Simpa Salami

Dr. Simpa Salami

Aug 3, 2023

Assistant Professor, Urology

Assistant Professor, Urology

University of Michigan Health Michigan Medicine

Simpa S. Salami, M.D., M.P.H., is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his MD from the College of Medicine, University of Ibadan, Nigeria. He completed a Master of Public Health program at Harvard University, a General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and a Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami is a translational surgeon-scientist whose research interests are in early detection and staging of prostate and kidney cancer. The goal of his research is to develop novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response.  Dr. Salami is a recipient of numerous awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, and Society of Urologic Oncology Young Investigator Awards. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation.

Go To Session: